eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | small cell carcinoma |
| Symptom | C0153690|bone metastases |
| Sentences | 11 |
| PubMedID- 22993373 | Feasibility study of zoledronic acid plus cisplatin-docetaxel as first-line treatment for advanced non-small cell lung cancer with bone metastases. |
| PubMedID- 24962716 | Background: to evaluate the efficacy of three-dimensional radiotherapy for non-small cell lung cancer (nsclc) patients with bone metastases. |
| PubMedID- 22174563 | Thus, a novel therapy for small cell lung cancer with bone metastases may be developed using peptide a from tcta protein. |
| PubMedID- 24052009 | Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients. |
| PubMedID- 20598769 | Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. |
| PubMedID- 23532208 | Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases. |
| PubMedID- 20556457 | However, it is unclear whether ntx is useful for monitoring therapeutic response in non-small cell lung cancer (nsclc) patients with bone metastases. |
| PubMedID- 24573639 | bone metastases occur in 30-40% of patients with advanced non-small cell lung cancer (nsclc). |
| PubMedID- 22959122 | Prognostic factor for non-small cell lung cancer with bone metastases at the time of diagnosis. |
| PubMedID- 26137132 | The present study aimed to analyze the clinical characteristics and prognosis-related factors of non-small cell lung cancer (nsclc) patients with bone metastases at the time of diagnosis. |
| PubMedID- 23749913 | Carboxy-terminal telopeptide (ctx) and amino-terminal propeptide (pinp) of type i collagen as markers of bone metastases in patients with non-small cell lung cancer. |
Page: 1